SCHEMBL26437446

SCHEMBL26437446

CN(N)C(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1860593 0.79
SCHEMBL2550342 0.78
SCHEMBL29733039 0.78 MEN1 (0.33)
SCHEMBL1106444 0.76
Hydrochloric Acid SCHEMBL31646882 0.75 NOTUM (0.36)
SCHEMBL19091449 0.73 MEN1 (0.34)
SCHEMBL24336864 0.73 MEN1 (0.31)
SCHEMBL29271885 0.73
SCHEMBL3280248 0.71
SCHEMBL4731734 0.71 MEN1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137663-A2 TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS EMPIRICO INC. (US) 2024-06-27 WO disclosed
WO-2024129886-A2 TREATMENT OF MST1 RELATED DISEASES AND DISORDERS EMPIRICO INC. (US) 2024-06-20 WO disclosed
EP-4175001-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY Mitsubishi Chemical Corporation (JP) 2023-05-03 EP disclosed